Presence of Chronic Obstructive Pulmonary Disease (COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide, Population-Based Cohort Study

The emergence of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) caused a paradigm shift in the treatment of non-small cell lung cancer (NSCLC). Although several clinicopathologic factors to predict the response to and survival on EGFR-TKI were recognized, its efficacy has not...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chia-Che, Rau, Kun-Ming, Lee, Wei-Chieh, Hsieh, Meng-Che, Liu, Jia-Sin, Chen, Yen-Yang, Su, Harvey Yu-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678274/
https://www.ncbi.nlm.nih.gov/pubmed/31336878
http://dx.doi.org/10.3390/jcm8071024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678274/
https://www.ncbi.nlm.nih.gov/pubmed/31336878
http://dx.doi.org/10.3390/jcm8071024

Ejemplares similares